Michelle L. O’Donoghue, MD, MPH

Opinion

Drugs to Target Lp(a): What’s Coming

Author:: Michelle L. O’Donoghue, MD, MPH

Publish date: December 18, 2024

Hopefully in the not-too-distant future, we’ll have specific therapies that really enable for us to address Lp(a) quite definitively.

Opinion

Don’t fear POTS: Tips for diagnosis and treatment

Author:: Michelle L. O’Donoghue, MD, MPH

Publish date: October 10, 2023

Sometimes that combination of a heart rate-lowering medication and a medication that increases blood pressure really works well.

Opinion

Is complete revascularization now compulsory? MULTISTARS-AMI and FIRE in context

Author:: Michelle L. O’Donoghue, MD, MPH

Publish date: September 12, 2023

We now have more data to support a complete revascularization strategy and even extending that to non-STEMI patients.

Opinion

Low-dose colchicine for ASCVD: Your questions answered

Author:: Michelle L. O’Donoghue, MD, MPH

Publish date: August 11, 2023

“It’s safe, it works, and it’s fully consistent with all the information we have about inflammation being part and parcel of atherosclerosis. It’s ...